Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Methotrexate therapy for psoriasis may help regrow hair in some cases of male pattern baldness.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

Melatonin improved mental health and metabolism in women with PCOS.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

PCOS treatment combines lifestyle changes and medication to manage symptoms and reduce health risks.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

A woman's severe skin reaction was caused by an allergy to a skin treatment.